Latest TMR Report Explores Impact of COVID-19 Outbreak on Hospital Disinfectant Products Market

According to a new market report published by Transparency Market Research titled ‘Hospital Disinfectant Products Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 – 2026,’ the global hospital disinfectant products market was valued at US$ 10,845.74 Mn in 2017. It is expected to reach US$ 17,192.96 Mn in terms of revenue by 2026, expanding at a CAGR of 5.3% from 2018 to 2026. The market in Asia Pacific is likely to expand at a rapid growth rate during the forecast period from 2018 to 2026, due to increase in prevalence of infectious diseases in countries in Southeast Asia, presence of a large number of distribution channels, and launch of new hospital disinfectant products by major manufacturers.

Factors such as increase in number of hospital-acquired/associated infections (HAI) across regions, increase in the number of minimally invasive surgeries, and rise in need for extensive use of medical instruments are expected to increase the demand for hospital disinfectant products during the forecast period. Apart from this, rise in stringent regulations in the medical sector regarding maintaining hygiene and cleanliness is expected to increase the adoption of hospital disinfectant products during the forecast period.

Request A Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=62853

In terms of type, the liquid segment is likely to offer significant expansion opportunities as liquid disinfectants are easy to reach surfaces or corners and are long lasting.

The water cleaner products market is expected to expand at a rapid pace during the forecast period. Increase in awareness about water safety and quality, scarcity of potable water resources, and rising health concerns are expected to boost the water cleaner products market.

Based on region, Europe accounted for a dominant share of the hospital disinfectant products market in 2017. North America also accounted for a prominent share in the market. The market in North America is primarily driven by the rapidly increasing geriatric population and their admission to hospitals, high adoption of surgical treatment in clinics, and the rising incidence of infectious diseases among the population in the U.S.

Prominent market players profiled in the research report include Colgate-Palmolive Company, Contec Inc., Becton, Dickinson And Company, Ecolab Inc., Georgia-Pacific LLC, GOJO Industries, Inc., Henry Schein Inc., Johnson & Johnson, Kimberly-Clark Corporation, Reckitt Benckiser plc., S. C. Johnson & Son, Inc, The Clorox Company, The Procter & Gamble Company, 3M Company, Belimed AG, Getinge AB, SAKURA SI Co. Ltd, Steelco S.p.A., STERIS PLC, Terragene S.A., Tuttnauer, Atlas Medical Software, Baxter International Inc, Premier, Inc., Quantros, Inc., RL Solutions, Truven Health Analytics Inc., VigiLanz Corporation, and Wolters Kluwer N.V